International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
DePaul-2026
IC-AIRCM-T3-2026
NSSFIGTMA-2025
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 4
July-August 2026
Indexing Partners
Bidirectional Linkages Between Sarcopenia and Type 2 Diabetes Mellitus in Older Adults: Mechanisms, Clinical Implications, and Therapeutic Interventions
| Author(s) | Dr. JEEVA GEORGE, Dr. MOHAMMED KHAJA MOINUDEEN, Dr. ARSALAAN AHMAD KHAN, Ms. KHUSHI DINESH |
|---|---|
| Country | India |
| Abstract | Background: Sarcopenia and type 2 diabetes mellitus (T2DM) frequently coexist in the geriatric population, creating a synergistic pathological loop that accelerates functional decline, disability, and mortality. While T2DM impairs skeletal muscle quality and accelerates muscle mass loss through chronic low-grade inflammation, insulin resistance, and advanced glycation end-product (AGE) accumulation, sarcopenia exacerbates glycemic dysregulation by reducing the primary site of insulin-mediated glucose disposal. Objective: This review explores the pathophysiological cross-talk between sarcopenia and T2DM, evaluates current diagnostic paradigms, assesses clinical consequences, and synthesizes evidence-based management strategies tailored for older adults. Methods: A comprehensive literature review was performed utilizing major biomedical databases, synthesizing recent clinical trials, consensus guidelines, and mechanistic studies up to 2026. Results: Sarcopo-diabetes—the concurrent presentation of sarcopenia and diabetes—amplifies the risk of cardiovascular disease, falls, and frailty compared to either condition alone. Diagnostic criteria require a tripartite evaluation of muscle mass, muscle strength, and physical performance. Management necessitates a multi-modal approach combining progressive resistance training (PRT), individualized nutritional optimization (higher protein targets with leucine supplementation), and pharmacological agents that preserve or enhance muscle mass (such as GLP-1 receptor agonists and SGLT2 inhibitors) while minimizing hypoglycemic events. Conclusion: Early identification and integrated management of sarcopenia in older patients with T2DM are essential to preserve functional independence and mitigate metabolic morbidity. |
| Field | Medical / Pharmacy |
| Published In | Volume 8, Issue 4, July-August 2026 |
| Published On | 2026-08-08 |
Share this

E-ISSN 2582-2160
CrossRef DOI prefix of IJFMR is 10.36948/ijfmr
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals